Researcher Profile

Im, Joo-Young image
Im, Joo-Young(임주영) 51

Biotherapeutics Translational Research Center (바이오신약중개연구센터)

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 51 (Search time: 0.007 seconds).

No. Year Title Type
51 2024

2024Article

CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathwaysExperimental and Molecular Medicine, vol. 56, no. 1, pp. 235-249Joo-Young Im; S J Kim; Jong Lyul Park; Tae Hee Han; Woo-Il Kim; Inhyub Kim; Bomin Ko; So-Young Chun; Mi-Jung KangBo Kyung Kim, et al.
Article
50 2023

2023Patent

DDIAS 억제제 및 사멸 수용체 리간드를 포함하는 암의 예방 또는 치료용 조성물KR10-2017-0115249 (2017.09.08) / 10-2532779 (2023.05.10)원미선; 임주영반현승김보경
Patent
49 2023

2023Article

TNF-α secreted from macrophages increases the expression of prometastatic integrin αV in gastric cancerInternational Journal of Molecular Sciences, vol. 24, no. 1, pp. 376-376Mi Aie Hwang; Misun Won; Joo-Young ImMi-Jung Kang; D H Kweon; Bo Kyung Kim
Article
48 2023

2023Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
47 2023

2023Article

Design, synthesis and biological evaluation of novel MDH inhibitors targeting tumor microenvironmentPharmaceuticals, vol. 16, no. 5, pp. 683-683S Godesi; Jeong-Ran Han; Jang Keun Kim; D I Kwak; J Lee; H Nada; M Kim; Hyun A Yang; Joo-Young ImHyun Seung Ban, et al.
Article
46 2023

2023Article

DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancerExperimental and Molecular Medicine, vol. 55, no. 5, pp. 879-885Joo-Young ImMi-Jung KangBo Kyung Kim; Mi Sun Won
Article
45 2023

2023Research Project

MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2023.03.01 ~ 2024.02.29
Research Project
44 2022

2022Patent

세포 내 존재 단백질과 세포 외부로 분비되는 단백질을 동시 발현하는 이중 발현벡터를 포함하는 암의 예방 또는 치료용 조성물KR10-2021-0039575 (2021.03.26) / 10-2393402 (2022.04.27)원미선; 임주영
Patent
43 2022

2022Article

Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesisJournal of Experimental & Clinical Cancer Research, vol. 41, pp. 212-212Bo Kyung Kim; Da Mi Kim; Hyunkyung Park; Seon-Kyu Kim; Mi Aie Hwang; Jungwoon LeeMi-Jung Kang; Jae Eun Byun; Joo-Young ImMinho Kang, et al.
Article
42 2022

2022Research Project

암대사를 조절하는 MDH1/2 이중 저해 항암물질 개발 = Development of anti-cancer drug MDH1/2 dual inhibitor controling cancer metabolism연구책임자 : 원미선 / 사업기간 : 2022.01.01 ~ 2023.06.30
Research Project
41 2022

2022Article

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyExperimental and Molecular Medicine, vol. 54, no. 8, pp. 1236-1249Haejeong Heo; Jong-Hwan Kim; Hyun Jung Lim; Jeong Hwan Kim; M Kim; J Koh; Joo-Young ImBo Kyung Kim; Mi Sun Won; Ji Hwan Park, et al.
Article
40 2022

2022Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
39 2022

2022Research Project

MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2022.03.01 ~ 2023.02.28
Research Project
38 2021

2021Patent

cyb5R3 유전자 또는 단백질을 유효성분으로 포함하는 암 예방 및 치료용 약학적 조성물US15/087,563 (2016.03.31) / 10,973,884 (2021.04.13)김동욱; 원미선; 김보경; 이영주; 오경진임주영반현승
Patent
37 2021

2021Article

DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathwayExperimental and Molecular Medicine, vol. 53, no. 4, pp. 643-653Joo-Young ImBo Kyung Kim; S H Yoon; B C Cho; Y M Baek; Mi-Jung Kang; N Kim; Y D Gong; Mi Sun Won
Article
36 2021

2021Article

VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signalingBiochimica et Biophysica Acta-Molecular Cell Research, vol. 1868, pp. 118892-118892Joo-Young Im; Da Mi Kim; Hyunkyung Park; Mi-Jung Kang; Da Yoon Kijm; K Y Chang; Bo Kyung Kim; Mi Sun Won
Article
35 2021

2021Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
34 2021

2021Research Project

다중유전체 분석을 통한 비흡연폐암의 신규치료타겟 발굴 및 기전규명연구책임자 : 박경찬 / 사업기간 : 2021.01.01 ~ 2022.03.31
Research Project
33 2021

2021Research Project

MDH 저해제를 활용한 LKB1/KRAS-매개하는 암대사 조절 기전 연구 = Study on the LKB1/KRAS-mediated regulation of cancer metabolism using MDH inhibitor연구책임자 : 원미선 / 사업기간 : 2021.03.01 ~ 2022.02.28
Research Project
32 2021

2021Research Project

[BRIDGE+] 2020년도 대학협력기관 간 융복합 프로그램연구책임자 : 이홍원 / 사업기간 : 2021.09.01 ~ 2022.01.15
Research Project
1 2 3